On this episode of the MarketScale Healthcare podcast, Dr. Jeff Chabot, co-founder, director and inventor at Endocellutions, offered some knowledge on regenerative medicine using bone marrow therapies and reveals why the Marrow Cellution aspiration device is superior to traditional harvesting systems.
The AOSSM will hold its annual meeting this year from July 11 to July 14, 2019, in Boston Massachusetts. RANFAC is excited to be participating this year, and we look forward to meeting with you in person! In Booth 230, we will be showcasing two of our innovative solutions for autologous therapies at point-of-care.
Since 1984, Bob Adler served as Ranfac’s owner and president—titles previously held by his father, Herbert, who passed away in that same year. Circumstances were not always on his side, but after every bump in the road (of which there were many), he always persevered. This is clearly evidenced in what Bob considered his real life’s work—Ranfac. Bob grew the company from a tiny medical device manufacturing company to the state-of-the art facility it is today. At Ranfac, we like to trace our roots back to 1888, and we’re proud of that history. But truly, Ranfac—what it is today and where it will be tomorrow—began when Bob took the reins 35 years ago.